ML21239A247
| ML21239A247 | |
| Person / Time | |
|---|---|
| Site: | 03012150 |
| Issue date: | 08/18/2021 |
| From: | Folch L NRC/RGN-III |
| To: | Plankey L Northwest Health - Porter |
| References | |
| IR 2021001 | |
| Download: ML21239A247 (3) | |
See also: IR 015000202/2010001
Text
U.S. NUCLEAR REGULATORY COMMISSION
SAFETY INSPECTION REPORT AND COMPLIANCE INSPECTION
NRC FORM 591M PART 1
(07-2012)
REPORT NUMBER(S)
1. LICENSEE/LOCATION INSPECTED:
2. NRC/REGIONAL OFFICE
3. DOCKET NUMBER(S)
4. LICENSE NUMBER(S)
5. DATE(S) OF INSPECTION
LICENSEE:
The inspection was an examination of the activities conducted under your license as they relate to radiation safety and to compliance with the Nuclear
Regulatory Commission (NRC) rules and regulations and the conditions of your license. The inspection consisted of selective examinations of
procedures and representative records, interviews with personnel, and observations by the inspector. The inspection findings are as follows:
1.
Based on the inspection findings, no violations were identified.
2.
Previous violation(s) closed.
3.
The violations(s), specifically described to you by the inspector as non-cited violations, are not being cited because they were self-identified,
non-repetitive, and corrective action was or is being taken, and the remaining criteria in the NRC Enforcement Policy, to exercise
discretion, were satisfied.
4.
Non-cited violation(s) were discussed involving the following requirement(s):
During this inspection, certain of your activities, as described below and/or attached, were in violation of NRC requirements and are being
cited in accordance with NRC Enforcement Policy. This form is a NOTICE OF VIOLATION, which may be subject to posting in accordance
with 10 CFR 19.11.
(Violations and Corrective Actions)
Statement of Corrective Actions
I hereby state that, within 30 days, the actions described by me to the Inspector will be taken to correct the violations identified. This statement of
corrective actions is made in accordance with the requirements of 10 CFR 2.201 (corrective steps already taken, corrective steps which will be taken,
date when full compliance will be achieved). I understand that no further written response to NRC will be required, unless specifically requested.
TITLE
PRINTED NAME
SIGNATURE
DATE
LICENSEE'S
REPRESENTATIVE
NRC INSPECTOR
NRC FORM 591M PART 1 (07-2012)
BRANCH CHIEF
Northwest Health - Porter
85 E. U.S. Hwy6
Valparaiso, IN 46383
202101
030-12150
13-17073-01
August 18, 2021
Luis Nieves Folch
Region III
U. S. Nuclear Regulatory Commission
2443 Warrenville Road, Suite 210
Lisle, IL 60532-4352
Luis A. Nieves Folch
Digitally signed by Luis A. Nieves Folch
Date: 2021.08.26 10:19:00 -05'00'
Michael A. Kunowski
Digitally signed by Michael A. Kunowski
Date: 2021.08.26 11:16:28 -05'00'
From:
Nieves Folch, Luis
To:
loriplankey@nwhealthin.com
Subject:
Northwest Health Porter 591M NRC report
Date:
Friday, August 27, 2021 8:43:00 AM
Attachments:
Northwest Health Porter 591M(1)MK.pdf
Dear Mrs. Plankey
Attach is the clear 591 report for the inspection conducted on August 18, 2021. At this
point there is no further actions on your part.
In accordance with Title 10 of the Code of Federal Regulations 2.390 of the NRCs
Rules of Practice, a copy of this message will be available electronically for public
inspection in the NRCs Public Document Room or from the NRC's Agencywide
Documents Access and Management System (ADAMS), accessible from the NRCs
website at http://www.nrc.gov/reading-rm/adams.html.
Please feel free to contact me if you have any questions regarding this correspondence.
Thank you,
Luis Nieves
Health Physicist
U.S. Nuclear Regulatory Commission
Division of Nuclear Materials Safety
Office: (630) 829-9571
Fax: (630) 515-1259
(10-2020)
U.S. NUCLEAR REGULATORY COMMISSION
Materials Inspection Record
Page 1 of 1
NRC Form 592M (10-2020)
1. Licensee Name:
Northwest Health - Porter
2. Docket Number(s):
030-12150
3. License Number(s)
13-17073-01
4. Report Number(s):
2021001
5. Date(s) of Inspection:
August 18, 2021
6. Inspector(s):
Luis Nieves
7. Program Code(s):
02240
8. Priority:
2
9. Inspection Guidance Used:
87132
10. Licensee Contact Name(s):
Lori Plankey, CNMT
11. Licensee E-mail Address:
loriplankey@nwhealthin.com
12. Licensee Telephone Number(s):
219-983-8300
13. Inspection Type:
Initial
Routine
Announced
Non-Routine
Unannounced
Temporary Job Site
Field Office
Main Office
14. Locations Inspected:
Remote
15. Next Inspection Date (MM/DD/YYYY):
August 18, 2023
Normal
Reduced
Extended
No change
16. Scope and Observations:
This was an announced, routine inspection of a hospital authorized by its NRC license to use unsealed byproduct
material for diagnostic and therapeutic procedures under 10 CFR 35.100, 200, 300, 400, and 1000(Y-90). At the
time of the inspection, the licensee performed a comprehensive spectrum of diagnostic procedures. The nuclear
medicine department was staffed with six full-time nuclear medicine technologists (NMTs) who performed
approximately 80 diagnostic nuclear medicine procedures weekly and 25 PET diagnostic procedures also weekly.
The licensee has two hot labs at their main hospital one for nuclear medicine and one for PET open from Mondays
to Fridays. The licensee has not performed any manual brachytherapy since 2012, they did perform ten I-131, one
complete Xofigo treatment, and five Y-90 treatments in the last year. The licensee retains a consultant health
physicist to perform annual audits of the radiation safety program and calibrations.
PERFOMANCE OBSERVATIONS
The inspector conducted a tour of the nuclear medicine hot labs and discussed with the NMT package receipt,
surveys, and instrument quality control checks. The inspector observed the preparation and administration of one
bone scan. The NMTs demonstrated adequate knowledge of radiation safety principles and practices through
interviews. The inspector reviewed audit reports, instrument quality control, safety committee minutes, written
directives, inventory, dose calibrator linearity and accuracy, leak tests, and training. The inspector also reviewed
monthly dosimetry reports which indicated annual whole-body and extremity doses were below regulatory limits.
No violations of NRC requirements were identified as a result of this inspection.